Rights and permissions
About this article
Cite this article
Weekly docetaxel + epirubicin promising for advanced prostate cancer. Inpharma Wkly. 1580, 13 (2007). https://doi.org/10.2165/00128413-200715800-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715800-00028